✨ Free AI Report
MatsukiyoCocokara & Co.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research MatsukiyoCocokara & Co.
Company Research

MatsukiyoCocokara & Co.: Business Overview, Financials & Competitive Analysis

MatsukiyoCocokara & Co. scores 7/10 on the AskCyborg Cyborg Score (Strong). Market-leading Japanese health and beauty retailer with solid fundamentals and omnichannel capabilities, but facing moderate valuation headwinds in domestic market. Dominant market position in Japanese pharmaceutical retail with established omnichannel strategy combining physical stores and e-commerce. Strong merger integration and brand portfolio, though valuation metrics suggest premium pricing relative.

What is MatsukiyoCocokara & Co.'s industry? MatsukiyoCocokara & Co. (matsukiyococokara.com) operates in Pharmaceutical Retailers. AskCyborg classifies MatsukiyoCocokara & Co. under Pharmaceutical Retailers in its company registry.

MatsukiyoCocokara & Co. operates and manages chain stores, drug stores, and insurance dispensing pharmacies in Japan. The company was established through the strategic merger of Matsumoto Kiyoshi Co., Ltd. and Cocokar...

7/ 10Strong

Cyborg Score thesis

Market-leading Japanese health and beauty retailer with solid fundamentals and omnichannel capabilities, but facing moderate...

Read the full analyst-debate transcript →
Industry Pharmaceutical Retailers
4 named competitors
2 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest MatsukiyoCocokara & Co. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for MatsukiyoCocokara & Co.

AskCyborg analysts argue the bull and bear cases for MatsukiyoCocokara & Co. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
MatsukiyoCocokara & Co. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

MatsukiyoCocokara & Co. Overview

Pro stress-test →

MatsukiyoCocokara & Co. operates and manages chain stores, drug stores, and insurance dispensing pharmacies in Japan. The company was established through the strategic merger of Matsumoto Kiyoshi Co., Ltd. and Cocokara Fine Inc., finalized in October 2021. It is one of Japan's largest pharmaceutical retail chains.

Strategic Profile

Pro stress-test →

The consolidation symbolizes a strategic shift to dominate the health and beauty market, combining the robust supply chain and extensive brand recognition of both entities. MatsukiyoCocokara & Co. is adept at navigating the digital realm with e-commerce platforms that complement its brick-and-mortar presence, and this dual-channel approach not only augments sales volume but also fortifies its market positioning within Japan and sets a sound foundation for potential overseas expansion.

Competitive Landscape

Pro stress-test →

Major competitors in pharmaceutical retail include Welcia Holdings, Sundrug Co., Sugi Holdings, and Tsuruha Holdings. MatsukiyoCocokara maintains competitive advantage through brand recognition, store density, and omnichannel integration.

Industry Context

MatsukiyoCocokara & Co. operates in Pharmaceutical Retailers.

Key facts

Founded: 1932 · Headquarters: Tokyo, Japan · Employees: 12,753-27,575 · Market cap: ¥1.019-1.34T

What the analysts stress-tested

The top findings that survived the multi-agent debate for MatsukiyoCocokara & Co..

  • Market consolidation achieved through strategic 2021 merger creating Japan's integrated health and wellness leader
  • Omnichannel expansion with e-commerce complementing 1,000+ physical store network across urban and suburban Japan
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Earnings report released with P/E ratio of 18.31 and dividend yield maintaining 1.85%
  • October 2021Strategic merger completion unifying Matsumoto Kiyoshi and Cocokara Fine operations
Get alerted when MatsukiyoCocokara & Co. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Tsuruha HoldingsJapanese pharmaceutical retail chain→SundrugDiscount pharmacy and health products retailer→Sugi HoldingsJapanese drugstore chain operator→Welcia HoldingsPharmacy and healthcare products retailer→

Compare MatsukiyoCocokara & Co. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

MatsukiyoCocokara & Co. operates in Pharmaceutical Retailers. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical Retailers research →
NEW · MCP server

Ask your AI assistant about MatsukiyoCocokara & Co.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare MatsukiyoCocokara & Co. and its top competitor on Cyborg Score”
“What did MatsukiyoCocokara & Co. do this quarter?”
“Is MatsukiyoCocokara & Co. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does MatsukiyoCocokara & Co. do?+
MatsukiyoCocokara & Co. operates and manages chain stores, drug stores, and insurance dispensing pharmacies in Japan. The company was established through the strategic merger of Matsumoto Kiyoshi Co., Ltd. and Cocokar...
What is MatsukiyoCocokara & Co.'s Cyborg Score?+
MatsukiyoCocokara & Co. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are MatsukiyoCocokara & Co.'s main competitors?+
Named competitors include Tsuruha Holdings, Sundrug, Sugi Holdings, Welcia Holdings. The full competitive landscape is in the AskCyborg report.
How can I get the full MatsukiyoCocokara & Co. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the MatsukiyoCocokara & Co. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track MatsukiyoCocokara & Co. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Pharmaceutical Retailers research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Clicks Group Limited6Sundrug Co., Ltd.